CareDx (CDNA) Misses Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. S
10. COF

Go back to CareDx (CDNA) Misses Q2 EPS by 1c

CareDx Reports Preliminary Second Quarter 2016 Financial Results

August 10, 2016 4:01 PM EDT

BRISBANE, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today reported preliminary financial results for the second quarter ended June 30, 2016.

Recent highlights:

Achieved total revenue for the second quarter of 2016 of $10.7 million AlloMap® revenues were $7.2 million in the quarterAlloMap patient results volumes in the U.S. were up by 12% year-over-yearOlerup® revenues contributed $3.4 million in the second quarter Advanced AlloSure®... More